Nicotinic acetylcholine receptor at the neuromuscular junction — Drug Target

All drugs that target Nicotinic acetylcholine receptor at the neuromuscular junction — marketed and clinical-stage. Includes 3 drug classes acting on this target.

Drug classes

Neuromuscular blocking agent (non-depolarizing) · Non-depolarizing neuromuscular blocking agent (NMBA) · Neuromuscular blocking agent

Marketed (6)

• Rocuronium or Vecuronium · Merck Sharp & Dohme LLC · Neuromuscular blocking agent (non-depolarizing) · Anesthesiology
  Rocuronium and vecuronium are neuromuscular blocking agents that competitively bind to acetylcholine receptors at the neuromuscular junction, preventing muscle contraction.
• NMBA - cisatracurium · CHU de Reims · Non-depolarizing neuromuscular blocking agent (NMBA) · Anesthesiology
  Cisatracurium is a non-depolarizing neuromuscular blocking agent that competitively antagonizes acetylcholine at the neuromuscular junction to produce skeletal muscle paralysis.
• Vecuronium + Atracurium · Sir Ganga Ram Hospital · Neuromuscular blocking agent (non-depolarizing) · Anesthesiology
  Vecuronium and atracurium are neuromuscular blocking agents that competitively inhibit acetylcholine at the neuromuscular junction, causing muscle paralysis.
• Neuromuscular Blocking Agents · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Neuromuscular blocking agent · Anesthesiology
  Neuromuscular blocking agents inhibit acetylcholine binding at the neuromuscular junction, preventing muscle contraction.
• Rocuronium dosing · Clare Hayes-Bradley · Neuromuscular blocking agent (non-depolarizing) · Anesthesia
  Rocuronium is a neuromuscular blocking agent that competitively binds to acetylcholine receptors at the neuromuscular junction, preventing muscle contraction.
• Deep neuromuscular block · University of Medicine and Pharmacy at Ho Chi Minh City · Anesthesiology
  Deep neuromuscular block refers to a state of profound neuromuscular blockade achieved through administration of neuromuscular blocking agents that inhibit acetylcholine at the neuromuscular junction.